Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects

PURPOSE: Verinurad (RDEA3170) is a selective uric acid reabsorption inhibitor in clinical development for the treatment of gout and asymptomatic hyperuricemia. The aim of this study was to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of verinurad in healthy adult males. SUBJECTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Zancong, Gillen, Michael, Miner, Jeffrey N, Bucci, Gail, Wilson, David M, Hall, Jesse W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511024/
https://www.ncbi.nlm.nih.gov/pubmed/28744099
http://dx.doi.org/10.2147/DDDT.S140658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511024/
https://www.ncbi.nlm.nih.gov/pubmed/28744099
http://dx.doi.org/10.2147/DDDT.S140658

Ejemplares similares